News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
398,384 Results
Type
Article (27062)
Company Profile (107)
Press Release (371215)
Multimedia
Podcasts (40)
Webinars (9)
Section
Business (102029)
Career Advice (538)
Deals (17994)
Drug Delivery (82)
Drug Development (38773)
Employer Resources (79)
FDA (10748)
Job Trends (9989)
News (175407)
Policy (20683)
Tag
Academia (2117)
Academic (2)
Accelerated approval (2)
Adcomms (12)
Allergies (55)
Alliances (28585)
ALS (44)
Alzheimer's disease (917)
Antibody-drug conjugate (ADC) (56)
Approvals (10810)
Artificial intelligence (205)
Autoimmune disease (14)
Automation (9)
Bankruptcy (148)
Best Places to Work (9003)
BIOSECURE Act (8)
Biosimilars (82)
Biotechnology (59)
Bladder cancer (47)
Brain cancer (13)
Breast cancer (163)
Cancer (1181)
Cardiovascular disease (127)
Career advice (494)
Career pathing (10)
CAR-T (56)
Cell therapy (205)
Cervical cancer (14)
Clinical research (32020)
Collaboration (518)
Compensation (64)
Complete response letters (5)
COVID-19 (2195)
CRISPR (25)
C-suite (143)
Cystic fibrosis (59)
Data (1364)
Decentralized trials (2)
Denatured (16)
Depression (30)
Diabetes (182)
Diagnostics (4905)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (23)
Drug discovery (72)
Drug pricing (95)
Drug shortages (10)
Duchenne muscular dystrophy (54)
Earnings (34213)
Editorial (24)
Employer branding (8)
Employer resources (70)
Events (72943)
Executive appointments (492)
FDA (11641)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (531)
Gene editing (49)
Generative AI (21)
Gene therapy (158)
GLP-1 (422)
Government (4154)
Grass and pollen (4)
Guidances (52)
Healthcare (15024)
Huntington's disease (10)
IgA nephropathy (17)
Immunology and inflammation (54)
Indications (19)
Infectious disease (2326)
Inflammatory bowel disease (91)
Inflation Reduction Act (10)
Influenza (48)
Intellectual property (46)
Interviews (58)
IPO (7731)
IRA (35)
Job creations (1406)
Job search strategy (448)
Kidney cancer (4)
Labor market (14)
Layoffs (177)
Leadership (5)
Legal (3911)
Liver cancer (43)
Lung cancer (161)
Lymphoma (78)
Machine learning (6)
Management (30)
Manufacturing (165)
MASH (44)
Medical device (9375)
Medtech (9378)
Mergers & acquisitions (10617)
Metabolic disorders (466)
Multiple sclerosis (52)
NASH (10)
Neurodegenerative disease (46)
Neuropsychiatric disorders (16)
Neuroscience (1238)
NextGen: Class of 2025 (4983)
Non-profit (3930)
Now hiring (7)
Obesity (252)
Opinion (121)
Ovarian cancer (30)
Pain (46)
Pancreatic cancer (31)
Parkinson's disease (79)
Partnered (13)
Patents (106)
Patient recruitment (71)
Peanut (30)
People (32693)
Pharmaceutical (32)
Pharmacy benefit managers (17)
Phase I (10194)
Phase II (12561)
Phase III (11397)
Pipeline (750)
Policy (113)
Postmarket research (1573)
Preclinical (3251)
Press Release (47)
Prostate cancer (62)
Psychedelics (23)
Radiopharmaceuticals (150)
Rare diseases (249)
Real estate (2842)
Recruiting (31)
Regulatory (14092)
Reports (20)
Research institute (1913)
Resumes & cover letters (40)
Rett syndrome (3)
RNA editing (3)
RSV (35)
Schizophrenia (46)
Series A (85)
Series B (63)
Service/supplier (4)
Sickle cell disease (49)
Special edition (8)
Spinal muscular atrophy (87)
Sponsored (18)
Startups (2089)
Stomach cancer (3)
Supply chain (47)
Tariffs (23)
The Weekly (23)
Vaccines (565)
Venture capitalists (25)
Weight loss (148)
Women's health (32)
Worklife (6)
Date
Today (101)
Last 7 days (479)
Last 30 days (1520)
Last 365 days (20671)
2025 (6898)
2024 (21778)
2023 (24258)
2022 (33687)
2021 (37126)
2020 (37569)
2019 (33252)
2018 (24878)
2017 (17708)
2016 (18858)
2015 (21430)
2014 (16060)
2013 (12721)
2012 (13464)
2011 (13905)
2010 (11929)
Location
Africa (515)
Alabama (26)
Alaska (6)
Arizona (123)
Arkansas (11)
Asia (21533)
Australia (3857)
California (3388)
Canada (1325)
China (305)
Colorado (175)
Connecticut (203)
Delaware (77)
Europe (48165)
Florida (560)
Georgia (163)
Hawaii (1)
Idaho (35)
Illinois (372)
India (22)
Indiana (274)
Iowa (7)
Japan (119)
Kansas (78)
Kentucky (16)
Louisiana (11)
Maine (66)
Maryland (632)
Massachusetts (2648)
Michigan (148)
Minnesota (231)
Mississippi (2)
Missouri (82)
Montana (16)
Nebraska (19)
Nevada (48)
New Hampshire (51)
New Jersey (1249)
New Mexico (11)
New York (1143)
North Carolina (660)
North Dakota (3)
Northern California (1519)
Ohio (132)
Oklahoma (9)
Oregon (23)
Pennsylvania (901)
Puerto Rico (7)
Rhode Island (20)
South America (674)
South Carolina (14)
South Dakota (1)
Southern California (1245)
Tennessee (88)
Texas (478)
United States (14411)
Utah (150)
Virginia (86)
Washington D.C. (45)
Washington State (380)
West Virginia (3)
Wisconsin (49)
398,384 Results for "alira health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alira Health Unveils 2024 Report on Antibody-Drug Conjugates Market
December 4, 2024
·
2 min read
Business
Alira Health Partners with Scottsdale Research Institute for Psilocybin Clinical Trials Funded by the State of ArizonaPartnership to Provide Regulatory and Clinical Support
Alira Health, a global advisory and clinical research firm, announced today its collaboration with the Scottsdale Research Institute (SRI) to provide comprehensive regulatory and clinical support with the goal to bring clinical research of psilocybin to the State of Arizona.
June 18, 2024
·
3 min read
Press Releases
Alira Health Releases Global Report on Trends and Competitive Dynamics in the Biosimilar Market
October 30, 2024
·
2 min read
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
Venture capitalists
Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill
Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity from taking control of the company to the detriment of other shareholders.
April 23, 2025
·
1 min read
·
Tristan Manalac
Government
Democrats Push Back on Trump Health Cuts With Lawsuits and Longest Ever Senate Speech
Nearly two dozen states on Tuesday sued the Department of Health and Human Services over a planned $11 billion funding cut for public health projects while New Jersey Senator Cory Booker spoke for 25 hours in protest of Trump administration policies.
April 2, 2025
·
2 min read
·
Tristan Manalac
Genetown
Myasthenia Gravis Foundation of America (MGFA) Re-launches the MGFA Global MG Patient Registry with Partner Alira Health
The Myasthenia Gravis Foundation of America (MGFA™), the largest, leading patient advocacy organization solely dedicated to the myasthenia gravis (MG) community re-launched its MGFA Global MG Patient Registry in partnership with Alira Health.
January 25, 2023
·
3 min read
Deals
Alira Health Expands North American Capabilities with the Acquisition of Artisan Healthcare Consulting
Alira Health, a patient-centric, global health care advisory, clinical research and technology company, announced the acquisition of Artisan Healthcare Consulting, a US-based consulting firm that provides strategic insights to healthcare companies.
September 6, 2022
·
3 min read
Business
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss the challenges of inclusion and exclusion criteria of clinical trial patients, and reflect on current investment approaches around women’s health.
March 13, 2025
·
1 min read
·
Lori Ellis
Deals
Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia
Alira Health, a global health care advisory and technology company, announced that it has acquired a full-service Contract Research Organization, Sourcia, that provides services for Phase I to Phase IV clinical trials with a focus on biotech, medical devices, and digital therapeutics.
April 5, 2022
·
2 min read
1 of 39,839
Next
